PALO ALTO, Calif., Oct. 2, 2017 /PRNewswire/ -- Varian (NYSE: VAR), global leader in radiotherapy treatments systems andsoftware, is announcing the publication of its annual Sustainability Report, detailing the company's policies and achievements in extending access to cancer care, protecting resources, and helping to save lives. The Varian 2017 Sustainability Report
"This is a company that utilizes its resources and talent to help people everywhere in the world," said Dow Wilson, Varian's chief executive officer. "Sustainability for us is extending access to quality healthcare, delivering safe and effective products, and having a beneficial impact on the communities where we operate."
"We have made a commitment to produce annual updates so we could measure our achievements against defined sustainability goals," added Wilson. "This effort involves the close participation of senior leaders from all divisions, key geographies, and core functions."
Varian's new Halcyon™ treatment system is highlighted in the report for its ability to extend affordable, accessible, high quality care globally while emphasizing sustainability through innovative design. The report also spotlights ongoing reductions in electricity and gas consumption, along with progress towards greenhouse gas emission reduction goals.
The report outlines the governance structure that determines Varian's sustainability activities and measures performance against goals stated in its inaugural report. Based on internationally-recognized GRI (global reporting initiative) parameters, this year's report has been prepared in accordance with the new GRI Standards.
About Varian Medical Systems Varian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,600 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
View original content:http://www.prnewswire.com/news-releases/varian-publishes-2017-sustainability-report-300528923.html
SOURCE Varian Medical Systems
Subscribe to our Free Newsletters!
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...View All